nodes	percent_of_prediction	percent_of_DWPC	metapath
Suramin—F2—hepatic artery—colon cancer	0.0722	0.126	CbGeAlD
Suramin—F2—portal vein—colon cancer	0.0627	0.109	CbGeAlD
Suramin—F2—vein—colon cancer	0.0361	0.0628	CbGeAlD
Suramin—SIRT1—endothelium—colon cancer	0.0235	0.0409	CbGeAlD
Suramin—SIRT1—blood vessel—colon cancer	0.0217	0.0377	CbGeAlD
Suramin—P2RY2—epithelium—colon cancer	0.0206	0.0358	CbGeAlD
Suramin—P2RY2—renal system—colon cancer	0.0191	0.0332	CbGeAlD
Suramin—PLA2G4A—Raltitrexed—Methotrexate—colon cancer	0.0145	1	CbGdCrCtD
Suramin—F2—endothelium—colon cancer	0.0124	0.0216	CbGeAlD
Suramin—SIRT5—renal system—colon cancer	0.0118	0.0205	CbGeAlD
Suramin—F2—blood vessel—colon cancer	0.0114	0.0199	CbGeAlD
Suramin—P2RX4—renal system—colon cancer	0.0112	0.0194	CbGeAlD
Suramin—F2—gall bladder—colon cancer	0.0108	0.0187	CbGeAlD
Suramin—SIRT1—epithelium—colon cancer	0.0105	0.0183	CbGeAlD
Suramin—SIRT1—renal system—colon cancer	0.00978	0.017	CbGeAlD
Suramin—ARSA—renal system—colon cancer	0.00966	0.0168	CbGeAlD
Suramin—RYR1—smooth muscle tissue—colon cancer	0.00938	0.0163	CbGeAlD
Suramin—SIRT5—vagina—colon cancer	0.00855	0.0149	CbGeAlD
Suramin—P2RX4—bone marrow—colon cancer	0.00844	0.0147	CbGeAlD
Suramin—SIRT1—lymphoid tissue—colon cancer	0.00812	0.0141	CbGeAlD
Suramin—P2RX4—vagina—colon cancer	0.00808	0.0141	CbGeAlD
Suramin—SIRT1—digestive system—colon cancer	0.00802	0.014	CbGeAlD
Suramin—ARSA—lymphoid tissue—colon cancer	0.00802	0.014	CbGeAlD
Suramin—ARSA—digestive system—colon cancer	0.00792	0.0138	CbGeAlD
Suramin—SIRT1—bone marrow—colon cancer	0.00739	0.0129	CbGeAlD
Suramin—PLA2G2A—epithelium—colon cancer	0.00738	0.0128	CbGeAlD
Suramin—SIRT5—liver—colon cancer	0.00721	0.0125	CbGeAlD
Suramin—PLA2G2A—smooth muscle tissue—colon cancer	0.00711	0.0124	CbGeAlD
Suramin—SIRT1—vagina—colon cancer	0.00708	0.0123	CbGeAlD
Suramin—ARSA—vagina—colon cancer	0.00699	0.0122	CbGeAlD
Suramin—PLA2G2A—renal system—colon cancer	0.00685	0.0119	CbGeAlD
Suramin—P2RX4—liver—colon cancer	0.00682	0.0119	CbGeAlD
Suramin—RYR1—vagina—colon cancer	0.00654	0.0114	CbGeAlD
Suramin—SIRT1—liver—colon cancer	0.00597	0.0104	CbGeAlD
Suramin—ARSA—liver—colon cancer	0.0059	0.0103	CbGeAlD
Suramin—PLA2G2A—lymphoid tissue—colon cancer	0.00568	0.00989	CbGeAlD
Suramin—PLA2G2A—digestive system—colon cancer	0.00561	0.00977	CbGeAlD
Suramin—F2—epithelium—colon cancer	0.00557	0.0097	CbGeAlD
Suramin—SIRT5—lymph node—colon cancer	0.00553	0.00962	CbGeAlD
Suramin—RYR1—liver—colon cancer	0.00552	0.00961	CbGeAlD
Suramin—P2RX4—lymph node—colon cancer	0.00523	0.0091	CbGeAlD
Suramin—F2—renal system—colon cancer	0.00517	0.009	CbGeAlD
Suramin—PLA2G4A—smooth muscle tissue—colon cancer	0.00494	0.00861	CbGeAlD
Suramin—PLA2G4A—renal system—colon cancer	0.00476	0.00828	CbGeAlD
Suramin—SIRT1—lymph node—colon cancer	0.00458	0.00797	CbGeAlD
Suramin—ARSA—lymph node—colon cancer	0.00452	0.00787	CbGeAlD
Suramin—F2—lymphoid tissue—colon cancer	0.00429	0.00747	CbGeAlD
Suramin—F2—digestive system—colon cancer	0.00424	0.00738	CbGeAlD
Suramin—PLA2G2A—liver—colon cancer	0.00418	0.00728	CbGeAlD
Suramin—F2—bone marrow—colon cancer	0.00391	0.0068	CbGeAlD
Suramin—PLA2G4A—bone marrow—colon cancer	0.0036	0.00626	CbGeAlD
Suramin—PLA2G4A—vagina—colon cancer	0.00345	0.006	CbGeAlD
Suramin—PLA2G2A—lymph node—colon cancer	0.00321	0.00558	CbGeAlD
Suramin—F2—liver—colon cancer	0.00316	0.0055	CbGeAlD
Suramin—PLA2G4A—lymph node—colon cancer	0.00223	0.00388	CbGeAlD
Suramin—F2—Regulation of Actin Cytoskeleton—FGFR3—colon cancer	0.000709	0.00172	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—EP300—colon cancer	0.000702	0.00171	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—SRC—colon cancer	0.000701	0.00171	CbGpPWpGaD
Suramin—PLA2G2A—Spinal Cord Injury—TP53—colon cancer	0.000688	0.00167	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.000677	0.00165	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000673	0.00164	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—VEGFA—colon cancer	0.000665	0.00162	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.000665	0.00162	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CDX2—colon cancer	0.000664	0.00162	CbGpPWpGaD
Suramin—SIRT1—Integrated Breast Cancer Pathway—AKT1—colon cancer	0.000664	0.00161	CbGpPWpGaD
Suramin—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—colon cancer	0.000659	0.0016	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000651	0.00158	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—APC—colon cancer	0.000651	0.00158	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000648	0.00158	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—BRAF—colon cancer	0.000644	0.00157	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00064	0.00156	CbGpPWpGaD
Suramin—PLA2G2A—Phospholipid metabolism—PIK3CA—colon cancer	0.000627	0.00153	CbGpPWpGaD
Suramin—SIRT1—Circadian rythm related genes—TP53—colon cancer	0.000625	0.00152	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—EGFR—colon cancer	0.000614	0.00149	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—BRAF—colon cancer	0.000612	0.00149	CbGpPWpGaD
Suramin—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—colon cancer	0.000595	0.00145	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—PIK3CA—colon cancer	0.000568	0.00138	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—MUC2—colon cancer	0.000565	0.00137	CbGpPWpGaD
Suramin—F2—Folate Metabolism—TP53—colon cancer	0.000564	0.00137	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—SRC—colon cancer	0.000554	0.00135	CbGpPWpGaD
Suramin—SIRT1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.00055	0.00134	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—NRAS—colon cancer	0.000533	0.0013	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—HRAS—colon cancer	0.000525	0.00128	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—HRAS—colon cancer	0.000512	0.00125	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000509	0.00124	CbGpPWpGaD
Suramin—SIRT1—Cellular responses to stress—TP53—colon cancer	0.000503	0.00122	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000488	0.00119	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—CHST5—colon cancer	0.000476	0.00116	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ODC1—colon cancer	0.000476	0.00116	CbGpPWpGaD
Suramin—PLA2G4A—Fc-epsilon receptor I signaling in mast cells—AKT1—colon cancer	0.000464	0.00113	CbGpPWpGaD
Suramin—F2—Signaling Pathways—DLC1—colon cancer	0.000463	0.00113	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—KRAS—colon cancer	0.000459	0.00112	CbGpPWpGaD
Suramin—PLA2G4A—Endothelins—AKT1—colon cancer	0.000452	0.0011	CbGpPWpGaD
Suramin—PLA2G4A—AGE/RAGE pathway—AKT1—colon cancer	0.000436	0.00106	CbGpPWpGaD
Suramin—F2—Signaling Pathways—LGR5—colon cancer	0.000435	0.00106	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000424	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—DLC1—colon cancer	0.000424	0.00103	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—PIK3CA—colon cancer	0.000422	0.00103	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—SRC—colon cancer	0.000421	0.00102	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000417	0.00102	CbGpPWpGaD
Suramin—ARSA—Metabolism—ABCB1—colon cancer	0.000415	0.00101	CbGpPWpGaD
Suramin—ARSA—Metabolism—TYMS—colon cancer	0.000407	0.000991	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—NRAS—colon cancer	0.000405	0.000984	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—LGR5—colon cancer	0.000398	0.000969	CbGpPWpGaD
Suramin—ARSA—Metabolism of proteins—CTNNB1—colon cancer	0.000394	0.000958	CbGpPWpGaD
Suramin—F2—Cell surface interactions at the vascular wall—HRAS—colon cancer	0.00039	0.000949	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—NRAS—colon cancer	0.000384	0.000935	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—MYC—colon cancer	0.000377	0.000917	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00037	0.000901	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—EGFR—colon cancer	0.00035	0.000852	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—KRAS—colon cancer	0.000348	0.000847	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000344	0.000837	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000335	0.000814	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—PPARG—colon cancer	0.000333	0.000809	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000331	0.000806	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—KRAS—colon cancer	0.000331	0.000805	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000328	0.000799	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.000324	0.000788	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—PIK3CA—colon cancer	0.00032	0.000778	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—FGFR3—colon cancer	0.000316	0.000769	CbGpPWpGaD
Suramin—ARSA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000313	0.000763	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AXIN2—colon cancer	0.000313	0.000761	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.000308	0.00075	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—FGFR3—colon cancer	0.000305	0.000743	CbGpPWpGaD
Suramin—F2—Regulation of Actin Cytoskeleton—PIK3CA—colon cancer	0.000304	0.00074	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.0003	0.000729	CbGpPWpGaD
Suramin—PLA2G4A—PDGFR-beta signaling pathway—HRAS—colon cancer	0.000296	0.00072	CbGpPWpGaD
Suramin—PLA2G4A—Phospholipid metabolism—PIK3CA—colon cancer	0.000296	0.000719	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000292	0.00071	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—SRC—colon cancer	0.000291	0.000709	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—APC—colon cancer	0.00029	0.000706	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—NRAS—colon cancer	0.00029	0.000706	CbGpPWpGaD
Suramin—ARSA—Metabolism—PPARG—colon cancer	0.000288	0.000702	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—colon cancer	0.000287	0.000697	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AXIN2—colon cancer	0.000286	0.000696	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.000284	0.000691	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—APC—colon cancer	0.00028	0.000682	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—NRAS—colon cancer	0.00028	0.000682	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000273	0.000664	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—BRAF—colon cancer	0.000273	0.000664	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000268	0.000653	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000268	0.000652	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—ABCB1—colon cancer	0.000267	0.00065	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—SRC—colon cancer	0.000267	0.000649	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—EGFR—colon cancer	0.000264	0.000643	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—BRAF—colon cancer	0.000264	0.000641	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000263	0.000639	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—TYMS—colon cancer	0.000262	0.000638	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—colon cancer	0.000261	0.000635	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.000261	0.000634	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—colon cancer	0.00026	0.000632	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—EGFR—colon cancer	0.000255	0.000621	CbGpPWpGaD
Suramin—F2—G alpha (q) signalling events—PIK3CA—colon cancer	0.000253	0.000617	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—PIK3CA—colon cancer	0.000253	0.000615	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—KRAS—colon cancer	0.00025	0.000608	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000248	0.000604	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—colon cancer	0.000247	0.0006	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—PIK3CA—colon cancer	0.000244	0.000594	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—KRAS—colon cancer	0.000241	0.000587	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—colon cancer	0.000238	0.00058	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—PIK3CA—colon cancer	0.00023	0.000558	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000228	0.000555	CbGpPWpGaD
Suramin—ARSA—Metabolism—PTGS2—colon cancer	0.000227	0.000552	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—colon cancer	0.000227	0.000552	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.000222	0.000539	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—PIK3CA—colon cancer	0.000222	0.000539	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00022	0.000536	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—HRAS—colon cancer	0.000212	0.000517	CbGpPWpGaD
Suramin—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—colon cancer	0.00021	0.00051	CbGpPWpGaD
Suramin—P2RY2—GPCR downstream signaling—AKT1—colon cancer	0.000206	0.000502	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—HRAS—colon cancer	0.000205	0.000499	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CASP3—colon cancer	0.000205	0.000498	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	0.000203	0.000493	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000202	0.000491	CbGpPWpGaD
Suramin—FSHR—GPCR downstream signaling—AKT1—colon cancer	0.000199	0.000485	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CCND1—colon cancer	0.000199	0.000485	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CASP3—colon cancer	0.000198	0.000481	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CTNNB1—colon cancer	0.000197	0.00048	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000197	0.000478	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—CDKN1A—colon cancer	0.000193	0.000469	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CCND1—colon cancer	0.000192	0.000468	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CTNNB1—colon cancer	0.00019	0.000463	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—MYC—colon cancer	0.00019	0.000462	CbGpPWpGaD
Suramin—ARSA—Metabolism—EP300—colon cancer	0.000189	0.000459	CbGpPWpGaD
Suramin—P2RY2—Signaling by GPCR—AKT1—colon cancer	0.000188	0.000456	CbGpPWpGaD
Suramin—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000186	0.000453	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—CDKN1A—colon cancer	0.000186	0.000453	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PPARG—colon cancer	0.000186	0.000452	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EP300—colon cancer	0.000183	0.000446	CbGpPWpGaD
Suramin—F2—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.000181	0.000441	CbGpPWpGaD
Suramin—FSHR—Signaling by GPCR—AKT1—colon cancer	0.000181	0.000441	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—SRC—colon cancer	0.000178	0.000434	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EP300—colon cancer	0.000177	0.000431	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—VEGFA—colon cancer	0.000174	0.000422	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—SRC—colon cancer	0.000172	0.000419	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—NRAS—colon cancer	0.000171	0.000417	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—VEGFA—colon cancer	0.000168	0.000408	CbGpPWpGaD
Suramin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—colon cancer	0.000166	0.000403	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—NRAS—colon cancer	0.000166	0.000403	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—MYC—colon cancer	0.00016	0.000389	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TGFB1—colon cancer	0.000159	0.000388	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—EGFR—colon cancer	0.000156	0.00038	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000155	0.000376	CbGpPWpGaD
Suramin—F2—Hemostasis—EP300—colon cancer	0.000154	0.000376	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—MYC—colon cancer	0.000154	0.000375	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TGFB1—colon cancer	0.000154	0.000374	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—EGFR—colon cancer	0.000151	0.000367	CbGpPWpGaD
Suramin—F2—Hemostasis—SRC—colon cancer	0.00015	0.000366	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—KRAS—colon cancer	0.000148	0.000359	CbGpPWpGaD
Suramin—F2—Hemostasis—VEGFA—colon cancer	0.000146	0.000356	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PTGS2—colon cancer	0.000146	0.000356	CbGpPWpGaD
Suramin—F2—Hemostasis—NRAS—colon cancer	0.000145	0.000352	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—KRAS—colon cancer	0.000143	0.000347	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—EP300—colon cancer	0.000141	0.000344	CbGpPWpGaD
Suramin—ARSA—Metabolism—PIK3CA—colon cancer	0.00014	0.00034	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—SRC—colon cancer	0.000137	0.000334	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—PIK3CA—colon cancer	0.000136	0.00033	CbGpPWpGaD
Suramin—F2—Hemostasis—TGFB1—colon cancer	0.000134	0.000327	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—VEGFA—colon cancer	0.000134	0.000326	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—NRAS—colon cancer	0.000132	0.000322	CbGpPWpGaD
Suramin—SIRT1—Gene Expression—AKT1—colon cancer	0.000132	0.00032	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—TP53—colon cancer	0.000131	0.000319	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—PIK3CA—colon cancer	0.000131	0.000319	CbGpPWpGaD
Suramin—F2—Metabolism of proteins—CTNNB1—colon cancer	0.000131	0.000318	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000129	0.000313	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—TP53—colon cancer	0.000127	0.000308	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—ABCB1—colon cancer	0.000126	0.000306	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—HRAS—colon cancer	0.000125	0.000305	CbGpPWpGaD
Suramin—F2—Hemostasis—KRAS—colon cancer	0.000124	0.000303	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—TYMS—colon cancer	0.000124	0.000301	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TGFB1—colon cancer	0.000123	0.000299	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—EP300—colon cancer	0.000122	0.000296	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—HRAS—colon cancer	0.000121	0.000295	CbGpPWpGaD
Suramin—F2—Hemostasis—PIK3CA—colon cancer	0.000114	0.000278	CbGpPWpGaD
Suramin—ARSA—Metabolism—AKT1—colon cancer	0.000114	0.000277	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—KRAS—colon cancer	0.000114	0.000277	CbGpPWpGaD
Suramin—P2RY2—Signaling Pathways—AKT1—colon cancer	0.000111	0.00027	CbGpPWpGaD
Suramin—F2—Hemostasis—TP53—colon cancer	0.000111	0.000269	CbGpPWpGaD
Suramin—FSHR—Signaling Pathways—AKT1—colon cancer	0.000107	0.00026	CbGpPWpGaD
Suramin—F2—Hemostasis—HRAS—colon cancer	0.000106	0.000257	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—PIK3CA—colon cancer	0.000105	0.000254	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—TP53—colon cancer	0.000101	0.000246	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—HRAS—colon cancer	9.67e-05	0.000235	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.52e-05	0.000232	CbGpPWpGaD
Suramin—F2—Hemostasis—AKT1—colon cancer	9.34e-05	0.000227	CbGpPWpGaD
Suramin—F2—Signaling Pathways—FGFR3—colon cancer	9.03e-05	0.00022	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—PIK3CA—colon cancer	8.99e-05	0.000219	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PPARG—colon cancer	8.76e-05	0.000213	CbGpPWpGaD
Suramin—PLA2G4A—Hemostasis—AKT1—colon cancer	8.54e-05	0.000208	CbGpPWpGaD
Suramin—F2—Signaling Pathways—APC—colon cancer	8.29e-05	0.000202	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—NRAS—colon cancer	8.29e-05	0.000202	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—FGFR3—colon cancer	8.26e-05	0.000201	CbGpPWpGaD
Suramin—F2—Signaling Pathways—BRAF—colon cancer	7.8e-05	0.00019	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—APC—colon cancer	7.59e-05	0.000185	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—NRAS—colon cancer	7.59e-05	0.000185	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—EGFR—colon cancer	7.56e-05	0.000184	CbGpPWpGaD
Suramin—PLA2G2A—Metabolism—AKT1—colon cancer	7.35e-05	0.000179	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—PIK3CA—colon cancer	7.22e-05	0.000176	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—KRAS—colon cancer	7.14e-05	0.000174	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—BRAF—colon cancer	7.13e-05	0.000174	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—EGFR—colon cancer	6.91e-05	0.000168	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PTGS2—colon cancer	6.89e-05	0.000168	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—PIK3CA—colon cancer	6.56e-05	0.00016	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—KRAS—colon cancer	6.53e-05	0.000159	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—HRAS—colon cancer	6.07e-05	0.000148	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—PIK3CA—colon cancer	6e-05	0.000146	CbGpPWpGaD
Suramin—F2—GPCR downstream signaling—AKT1—colon cancer	5.9e-05	0.000144	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CASP3—colon cancer	5.85e-05	0.000142	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—EP300—colon cancer	5.73e-05	0.000139	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CCND1—colon cancer	5.69e-05	0.000138	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CTNNB1—colon cancer	5.64e-05	0.000137	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—HRAS—colon cancer	5.55e-05	0.000135	CbGpPWpGaD
Suramin—F2—Signaling Pathways—CDKN1A—colon cancer	5.5e-05	0.000134	CbGpPWpGaD
Suramin—F2—Signaling by GPCR—AKT1—colon cancer	5.36e-05	0.00013	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CASP3—colon cancer	5.35e-05	0.00013	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EP300—colon cancer	5.24e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CCND1—colon cancer	5.2e-05	0.000127	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CTNNB1—colon cancer	5.15e-05	0.000125	CbGpPWpGaD
Suramin—F2—Signaling Pathways—SRC—colon cancer	5.09e-05	0.000124	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—CDKN1A—colon cancer	5.03e-05	0.000123	CbGpPWpGaD
Suramin—F2—Signaling Pathways—VEGFA—colon cancer	4.96e-05	0.000121	CbGpPWpGaD
Suramin—PLA2G4A—Signaling by GPCR—AKT1—colon cancer	4.9e-05	0.000119	CbGpPWpGaD
Suramin—F2—Signaling Pathways—NRAS—colon cancer	4.9e-05	0.000119	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EP300—colon cancer	4.79e-05	0.000117	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—SRC—colon cancer	4.66e-05	0.000113	CbGpPWpGaD
Suramin—F2—Signaling Pathways—MYC—colon cancer	4.56e-05	0.000111	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TGFB1—colon cancer	4.55e-05	0.000111	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—VEGFA—colon cancer	4.54e-05	0.00011	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—NRAS—colon cancer	4.48e-05	0.000109	CbGpPWpGaD
Suramin—F2—Signaling Pathways—EGFR—colon cancer	4.46e-05	0.000109	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—PIK3CA—colon cancer	4.24e-05	0.000103	CbGpPWpGaD
Suramin—F2—Signaling Pathways—KRAS—colon cancer	4.22e-05	0.000103	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—MYC—colon cancer	4.17e-05	0.000102	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TGFB1—colon cancer	4.16e-05	0.000101	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—EGFR—colon cancer	4.08e-05	9.94e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—PIK3CA—colon cancer	3.87e-05	9.43e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—KRAS—colon cancer	3.86e-05	9.39e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—TP53—colon cancer	3.75e-05	9.12e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—HRAS—colon cancer	3.58e-05	8.72e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—PIK3CA—colon cancer	3.54e-05	8.62e-05	CbGpPWpGaD
Suramin—PLA2G4A—Metabolism—AKT1—colon cancer	3.46e-05	8.42e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—TP53—colon cancer	3.43e-05	8.34e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—HRAS—colon cancer	3.28e-05	7.98e-05	CbGpPWpGaD
Suramin—F2—Signaling Pathways—AKT1—colon cancer	3.17e-05	7.7e-05	CbGpPWpGaD
Suramin—PLA2G4A—Signaling Pathways—AKT1—colon cancer	2.89e-05	7.04e-05	CbGpPWpGaD
